Effects of a mycotoxin deactivator in broilers exposed to subclinical doses of fumonisins and deoxynivalenol

Read full text Summarise with VIRAT
Authors: Joseph Rishitha Dasireddy, Laharika Kappari, Chasity M. Pender, Barbara Doupovec, Ramesh Kumar Selvaraj, Todd Jay Applegate, Revathi Shanmugasundaram
Cited by: 0
References: 69

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Feed ingredients used in poultry production are frequently co-contaminated with multiple mycotoxins, posing challenges that conventional binders alone may not offer comprehensive mycotoxin mitigation. Hence, this study evaluated the efficacy of mycotoxin deactivator, Biofix Select® with FUMzyme® (a multi-component mycotoxin deactivator) on growth performance, antioxidant activity, immune response, and cecal microbiota in broilers exposed to fumonisin (FBs) and deoxynivalenol (DON). A total of 360 one-day-old broiler chicks were randomly distributed in a 2 × 2 factorial design. The dietary treatments were: control, FBs + DON (8.5 mg FBs + 3.9 mg DON per kg of feed), Mycotoxin (MTX) Deactivator (0.1 % Biofix Select® with FUMzyme®), and FBs + DON + MTX Deactivator (0.1 % Biofix Select® with FUMzyme®) (n=6). Data were analyzed using two-way ANOVA. No interaction effects were observed for overall growth performance. However, significant interaction effects between FBs + DON exposure and MTX Deactivator supplementation were observed for gut morphology on d21, with the MTX Deactivator mitigating the reductions in villus length and crypt depth induced by FBs + DON (p < 0.05). On d35, interaction effects were observed in jejunal occludin (OCC) mRNA expression, with the MTX Deactivator counteracting the FBs + DON-induced downregulation of OCC (p < 0.05). On d35, interactions were detected in the percentages of CD8+ T cells and CD8+:CD4+ T cell ratios in the cecal tonsil and spleen (p < 0.05), with MTX Deactivator alleviating the immunosuppression caused by FBs + DON. A significant interaction was also observed in splenic TGF-β mRNA expression, where the MTX Deactivator decreased the TGF-β mRNA expression in birds exposed to FBs + DON (p < 0.05). In conclusion, the MTX Deactivator at 0.1 % mitigated the adverse effects resulting from continuous exposure to subclinical levels of combined FBs and DON in broilers.

Fields of Study & Subjects

Mycotoxins in Agriculture and Food Animal Nutrition and Physiology Phytase and its Applications

Publication details

Journal / source
Poultry Science
Volume
105
Issue
6
Pages
106843–106843
Publication date
22 March 2026
Language
EN